Increased expression of estrogen receptor β mRNA in tamoxifen-resistant breast cancer patients

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5421-5424

  Speirs, Valerie ^a,b   Malone, Carmel ^b   Walton, David S ^b   Kerin, Michael J ^b   Atkin, Stephen L ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; TAMOXIFEN;

ARTICLE; BREAST CANCER; DIAGNOSTIC VALUE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TAMOXIFEN; TESTIS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033231027     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Muss, H. B. Endocrine therapy for advanced breast cancer: a review. Breast Cancer Res. Treat., 21: 15-26, 1992.
2. MacGregor, J. I., and Jordan, V. C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev., 50: 151-196, 1998.
3. Miller, W. R., Hulme, M. J., Bartlett, J. M. S., MacCallum, J., and Dixon, J. M. Changes in messenger RNA expression of protein kinase A regulatory subunit Iα in breast cancer patients treated with tamoxifen. Clin. Cancer Res., 3: 2399-2404, 1997.
4. Thompson, A. M., Kerr, D. J., and Steel, C. M. Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancer. Br. J. Cancer, 63: 609-614, 1991.
5. Karnik, P. S., Kulkarni, S., Liu, X-P., Budd, T., and Bukowski, R. M. Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res., 54: 349-353, 1994.
6. Mosselman, S., Polman, J., and Dijkema, R. ER-β: identification and characterisation of a novel human estrogen receptor. FEBS Lett., 392: 49-53, 1996.
7. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. Estrogen receptor β messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestin. Cancer Res., 59: 529-532, 1999.
8. Speirs, V., Parkes, A. T., Kerin, M. J., Walton, D. S., Carleton, P. J., Fox, J. N., and Atkin, S. L. Coexpression of estrogen receptor α and β: poor prognostic factors in human breast cancer? Cancer Res., 59: 525-528, 1999.
9. Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustaffson, J-A., Kushner, P. J., and Scanlan, T. S. Differential ligand activation of estrogen receptors ERα and ERβ at AP-1 sites. Science (Washington DC), 277: 1508-1510, 1997.
10. Toi, M., Harris, A. L., and Bicknell, R. cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. Br. J. Cancer, 68: 1088-1096, 1993.
11. Green, V. L., Atkin, S. L., Speirs, V., Jeffreys, R. V., Landolt, A. M., Hipkin, L., and White, M. C. Cytokine expression in human anterior pituitary adenomas. Clin. Endocrinol., 45: 179-185, 1996.
12. Speirs, V., Green, A. R., and Atkin, S. L. Activity and gene expression of 17β-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of 1L-8. J. Steroid Biochem. Mol. Biol., 67: 267-274, 1998.
13. Howell, A., Defriend, D., Robertson, J., Blamey, R., and Walton, P. Response to a specific antiestrogen (ICI 182780) in tamoxifen resistant breast cancer. Lancet, 345: 29-30, 1995.
14. Arteaga, C. L., Koli, K. M., Dugger, T. C., and Clarke, R. Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-β. J. Natl. Cancer Inst., 91: 46-53, 1999.
15. Leygue, E., Dotslaw, H., Watson, P. H., and Murphy, L. C. Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res., 58: 3197-3201, 1998.
16. Leygue, E., Dotslaw, H., Watson, P. H., and Murphy, L. C. Expression of estrogen receptor β1, β2 and β5 messenger RNAs in human breast tissue. Cancer Res., 59; 1175-1179, 1999.
17. Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., and Gustafsson, J. A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology, 138: 863-870, 1997.
18. Cowley, S. M., Hoare, S., Mosselman, S., and Parker, M. G. Estrogen receptors α and β form heterodimers on DNA. J. Biol. Chem., 272: 19858-19862, 1997.
19. Pace, P., Taylor, J., Suntharalingam, S., Coombes, R. C., and Ali, S. Human estrogen receptor β binds DNA in a manner similar to and dimerizes with estrogen receptor α. J. Biol. Chem., 272: 25832-25838, 1997.
20. Tremblay, G., Tremblay, A., Copeland, N., Gilbert, D., Jenkins, N., Labrie, F., and Giguere, V. Cloning, chromosomal localisation and functional analysis of the murine estrogen receptor β. Mol. Endocrinol., 11, 353-365, 1997.
21. Horwitz, K. B., Jackson, T. A., Rain, D. L., Richer, J. K., Takimoto, G. S., and Tung, L. Nuclear coactivators and corepressors. Mol. Endocrinol., 10: 1167-1177, 1996.